Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 665

1.

GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE).

Carter J, Huang HQ, Armer J, Carlson JW, Lockwood S, Nolte S, Stewart BR, Kauderer J, Hutson A, Walker JL, Fleury AC, Bonebrake A, Soper JT, Mathews C, Zivanovic O, Richards WE, Tan A, Alberts DS, Barakat RR, Wenzel L.

Gynecol Oncol. 2019 Dec;155(3):452-460. doi: 10.1016/j.ygyno.2019.09.027. Epub 2019 Oct 31.

PMID:
31679787
2.

Effect of Intermittent Versus Continuous Low-Dose Aspirin on Nasal Epithelium Gene Expression in Current Smokers: A Randomized, Double-Blinded Trial.

Garland LL, Guillen-Rodriguez J, Hsu CH, Yozwiak M, Zhang HH, Alberts DS, Davis LE, Szabo E, Merenstein C, Lel J, Zhang X, Liu H, Liu G, Spira AE, Beane JE, Wojtowicz M, Chow HS.

Cancer Prev Res (Phila). 2019 Nov;12(11):809-820. doi: 10.1158/1940-6207.CAPR-19-0036. Epub 2019 Aug 26.

PMID:
31451521
3.

Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patients.

Fuh KC, Java JJ, Chan JK, Kapp DS, Monk BJ, Burger RA, Young RC, Alberts DS, McGuire WP, Markman M, Bell J, Ozols RF, Armstrong DK, Aghajanian C, Bookman MA, Mannel RS.

Gynecol Oncol. 2019 Aug;154(2):420-425. doi: 10.1016/j.ygyno.2019.05.013. Epub 2019 Jun 19.

PMID:
31229298
4.

Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk for Ovarian Cancer: An NRG Oncology Group/GOG Study.

Rodriguez GC, Kauderer J, Hunn J, Thaete LG, Watkin WG, Russell S, Yozwiak M, Basil J, Hurteau J, Lele S, Modesitt SC, Zivanovic O, Zhang HH, Bartels PH, Alberts DS.

Cancer Prev Res (Phila). 2019 Jun;12(6):401-412. doi: 10.1158/1940-6207.CAPR-18-0383. Epub 2019 Apr 23.

PMID:
31015198
5.

Randomized Trial of Intravenous Versus Intraperitoneal Chemotherapy Plus Bevacizumab in Advanced Ovarian Carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.

Walker JL, Brady MF, Wenzel L, Fleming GF, Huang HQ, DiSilvestro PA, Fujiwara K, Alberts DS, Zheng W, Tewari KS, Cohn DE, Powell MA, Van Le L, Davidson SA, Gray HJ, Rose PG, Aghajanian C, Myers T, Alvarez Secord A, Rubin SC, Mannel RS.

J Clin Oncol. 2019 Jun 1;37(16):1380-1390. doi: 10.1200/JCO.18.01568. Epub 2019 Apr 19. Erratum in: J Clin Oncol. 2019 Sep 1;37(25):2299.

PMID:
31002578
6.

Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development.

Pearson T, Caporaso JG, Yellowhair M, Bokulich NA, Padi M, Roe DJ, Wertheim BC, Linhart M, Martinez JA, Bilagody C, Hornstra H, Alberts DS, Lance P, Thompson PA.

Cancer Med. 2019 Feb;8(2):617-628. doi: 10.1002/cam4.1965. Epub 2019 Jan 16.

7.

Microproteomic Profiling of High-Grade Squamous Intraepithelial Lesion of the Cervix: Insight into Biological Mechanisms of Dysplasia and New Potential Diagnostic Markers.

Pottier C, Kriegsmann M, Alberts D, Smargiasso N, Baiwir D, Mazzucchelli G, Herfs M, Fresnais M, Casadonte R, Delvenne P, De Pauw E, Longuespée R.

Proteomics Clin Appl. 2019 Jan;13(1):e1800052. doi: 10.1002/prca.201800052. Epub 2018 Aug 23.

PMID:
30094940
8.

Economic Evaluation for the UK of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer.

Gharaibeh M, McBride A, Alberts DS, Erstad B, Slack M, Alsaid N, Bootman JL, Abraham I.

Pharmacoeconomics. 2018 Nov;36(11):1333-1343. doi: 10.1007/s40273-018-0684-8.

PMID:
29981004
9.

Economic Evaluation for USA of Systemic Chemotherapies as First-Line Treatment of Metastatic Pancreatic Cancer.

Gharaibeh M, McBride A, Alberts DS, Slack M, Erstad B, Alsaid N, Bootman JL, Abraham I.

Pharmacoeconomics. 2018 Oct;36(10):1273-1284. doi: 10.1007/s40273-018-0678-6.

PMID:
29948964
10.

Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer.

Gilligan AM, Alberts DS, Roe DJ, Skrepnek GH.

Am J Med. 2018 Oct;131(10):1187-1199.e5. doi: 10.1016/j.amjmed.2018.05.020. Epub 2018 Jun 13.

PMID:
29906429
11.

Celecoxib use and circulating oxylipins in a colon polyp prevention trial.

Martinez JA, Yang J, Wertheim BC, Roe DJ, Schriewer A, Lance P, Alberts DS, Hammock BD, Thompson PA.

PLoS One. 2018 Apr 26;13(4):e0196398. doi: 10.1371/journal.pone.0196398. eCollection 2018.

12.

Pharmacological TLR4 Antagonism Using Topical Resatorvid Blocks Solar UV-Induced Skin Tumorigenesis in SKH-1 Mice.

Blohm-Mangone K, Burkett NB, Tahsin S, Myrdal PB, Aodah A, Ho B, Janda J, McComas M, Saboda K, Roe DJ, Dong Z, Bode AM, Petricoin EF 3rd, Calvert VS, Curiel-Lewandrowski C, Alberts DS, Wondrak GT, Dickinson SE.

Cancer Prev Res (Phila). 2018 May;11(5):265-278. doi: 10.1158/1940-6207.CAPR-17-0349. Epub 2018 Feb 1.

13.

MALDI Imaging Combined with Laser Microdissection-Based Microproteomics for Protein Identification: Application to Intratumor Heterogeneity Studies.

Longuespée R, Alberts D, Baiwir D, Mazzucchelli G, Smargiasso N, De Pauw E.

Methods Mol Biol. 2018;1788:297-312. doi: 10.1007/7651_2017_114.

PMID:
29224050
14.

Protein activation mapping of human sun-protected epidermis after an acute dose of erythemic solar simulated light.

Einspahr JG, Curiel-Lewandrowski C, Calvert VS, Stratton SP, Alberts DS, Warneke J, Hu C, Saboda K, Wagener EL, Dickinson S, Dong Z, Bode AM, PetricoinIII EF.

NPJ Precis Oncol. 2017;1. pii: 34. doi: 10.1038/s41698-017-0037-7. Epub 2017 Sep 21.

15.

MALDI Imaging-Guided Microproteomic Analyses of Heterogeneous Breast Tumors-A Pilot Study.

Alberts D, Pottier C, Smargiasso N, Baiwir D, Mazzucchelli G, Delvenne P, Kriegsmann M, Kazdal D, Warth A, De Pauw E, Longuespée R.

Proteomics Clin Appl. 2018 Jan;12(1). doi: 10.1002/prca.201700062. Epub 2017 Sep 15.

PMID:
28801933
16.

Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.

Sereni MI, Baldelli E, Gambara G, Ravaggi A, Hodge KA, Alberts DS, Guillen-Rodriguez JM, Dong T, Memo M, Odicino F, Angioli R, Liotta LA, Pecorelli SL, Petricoin EF, Pierobon M.

Br J Cancer. 2017 Aug 8;117(4):494-502. doi: 10.1038/bjc.2017.195. Epub 2017 Jun 29.

17.

ADA-07 Suppresses Solar Ultraviolet-Induced Skin Carcinogenesis by Directly Inhibiting TOPK.

Gao G, Zhang T, Wang Q, Reddy K, Chen H, Yao K, Wang K, Roh E, Zykova T, Ma W, Ryu J, Curiel-Lewandrowski C, Alberts D, Dickinson SE, Bode AM, Xing Y, Dong Z.

Mol Cancer Ther. 2017 Sep;16(9):1843-1854. doi: 10.1158/1535-7163.MCT-17-0212. Epub 2017 Jun 27.

18.

A stratified randomized double-blind phase II trial of celecoxib for treating patients with cervical intraepithelial neoplasia: The potential predictive value of VEGF serum levels: An NRG Oncology/Gynecologic Oncology Group study.

Rader JS, Sill MW, Beumer JH, Lankes HA, Benbrook DM, Garcia F, Trimble C, Tate Thigpen J, Lieberman R, Zuna RE, Leath CA 3rd, Spirtos NM, Byron J, Thaker PH, Lele S, Alberts D.

Gynecol Oncol. 2017 May;145(2):291-297. doi: 10.1016/j.ygyno.2017.02.040. Epub 2017 Mar 10.

19.

Effects of Retinoids on Augmentation of Club Cell Secretory Protein.

Chen Y, Vasquez MM, Zhu L, Lizarraga RE, Krutzsch M, Einspahr J, Alberts DS, Di PYP, Martinez FD, Guerra S.

Am J Respir Crit Care Med. 2017 Oct 1;196(7):928-931. doi: 10.1164/rccm.201608-1611LE. No abstract available.

20.

Early Detection of Ovarian Cancer using the Risk of Ovarian Cancer Algorithm with Frequent CA125 Testing in Women at Increased Familial Risk - Combined Results from Two Screening Trials.

Skates SJ, Greene MH, Buys SS, Mai PL, Brown P, Piedmonte M, Rodriguez G, Schorge JO, Sherman M, Daly MB, Rutherford T, Brewster WR, O'Malley DM, Partridge E, Boggess J, Drescher CW, Isaacs C, Berchuck A, Domchek S, Davidson SA, Edwards R, Elg SA, Wakeley K, Phillips KA, Armstrong D, Horowitz I, Fabian CJ, Walker J, Sluss PM, Welch W, Minasian L, Horick NK, Kasten CH, Nayfield S, Alberts D, Finkelstein DM, Lu KH.

Clin Cancer Res. 2017 Jul 15;23(14):3628-3637. doi: 10.1158/1078-0432.CCR-15-2750. Epub 2017 Jan 31.

21.

Resatorvid-based Pharmacological Antagonism of Cutaneous TLR4 Blocks UV-induced NF-κB and AP-1 Signaling in Keratinocytes and Mouse Skin.

Janda J, Burkett NB, Blohm-Mangone K, Huang V, Curiel-Lewandrowski C, Alberts DS, Petricoin EF 3rd, Calvert VS, Einspahr J, Dong Z, Bode AM, Wondrak GT, Dickinson SE.

Photochem Photobiol. 2016 Nov;92(6):816-825. doi: 10.1111/php.12659. Epub 2016 Dec 8.

22.

Evaluating IPMN and pancreatic carcinoma utilizing quantitative histopathology.

Glazer ES, Zhang HH, Hill KA, Patel C, Kha ST, Yozwiak ML, Bartels H, Nafissi NN, Watkins JC, Alberts DS, Krouse RS.

Cancer Med. 2016 Oct;5(10):2841-2847. doi: 10.1002/cam4.923. Epub 2016 Sep 26.

23.

Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention.

Lance P, Alberts DS, Thompson PA, Fales L, Wang F, San Jose J, Jacobs ET, Goodman PJ, Darke AK, Yee M, Minasian L, Thompson IM, Roe DJ.

Cancer Prev Res (Phila). 2017 Jan;10(1):45-54. doi: 10.1158/1940-6207.CAPR-16-0104. Epub 2016 Oct 24.

24.

Bone loss after oophorectomy among high-risk women: an NRG oncology/gynecologic oncology group study.

Hibler EA, Kauderer J, Greene MH, Rodriguez GC, Alberts DS.

Menopause. 2016 Nov;23(11):1228-1232.

25.

Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow HH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez ME, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw152. doi: 10.1093/jnci/djw152. Print 2016 Dec.

26.

Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial.

Thompson PA, Ashbeck EL, Roe DJ, Fales L, Buckmeier J, Wang F, Bhattacharyya A, Hsu CH, Chow SH, Ahnen DJ, Boland CR, Heigh RI, Fay DE, Hamilton SR, Jacobs ET, Martinez EM, Alberts DS, Lance P.

J Natl Cancer Inst. 2016 Aug 16;108(12). pii: djw151. doi: 10.1093/jnci/djw151. Print 2016 Dec.

27.
28.

Therapy operating characteristic curves: tools for precision chemotherapy.

Barrett HH, Alberts DS, Woolfenden JM, Caucci L, Hoppin JW.

J Med Imaging (Bellingham). 2016 Apr;3(2):023502. doi: 10.1117/1.JMI.3.2.023502. Epub 2016 May 2.

29.

Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations.

Jacobs ET, Haussler MR, Alberts DS, Kohler LN, Lance P, Martínez ME, Roe DJ, Jurutka PW.

Cancer Prev Res (Phila). 2016 Jul;9(7):589-97. doi: 10.1158/1940-6207.CAPR-16-0033. Epub 2016 May 2.

30.

Fentanyl sublingual spray for breakthrough cancer pain in patients receiving transdermal fentanyl.

Alberts DS, Smith CC, Parikh N, Rauck RL.

Pain Manag. 2016 Oct;6(5):427-34. doi: 10.2217/pmt-2015-0009. Epub 2016 Mar 29.

31.

An Improved Molecular Histology Method for Ion Suppression Monitoring and Quantification of Phosphatidyl Cholines During MALDI MSI Lipidomics Analyses.

Jadoul L, Smargiasso N, Pamelard F, Alberts D, Noël A, De Pauw E, Longuespée R.

OMICS. 2016 Feb;20(2):110-21. doi: 10.1089/omi.2015.0165.

PMID:
26871868
32.

High Proportion of Nuclear Phenotype Identifies Aggressive Cutaneous Squamous Cell Carcinoma.

Glazer ES, Bartels PH, Liang J, Prasad AR, Yozwiak ML, Krutzsch M, Clark C, Kha S, Bartels HG, Einspahr JG, Alberts DS, Krouse RS.

Anal Quant Cytopathol Histpathol. 2015 Oct;37(5):302-9.

PMID:
26856115
33.

Inhibition of Akt Enhances the Chemopreventive Effects of Topical Rapamycin in Mouse Skin.

Dickinson SE, Janda J, Criswell J, Blohm-Mangone K, Olson ER, Liu Z, Barber C, Petricoin EF 3rd, Calvert VS, Einspahr J, Dickinson JE, Stratton SP, Curiel-Lewandrowski C, Saboda K, Hu C, Bode AM, Dong Z, Alberts DS, Timothy Bowden G.

Cancer Prev Res (Phila). 2016 Mar;9(3):215-24. doi: 10.1158/1940-6207.CAPR-15-0419. Epub 2016 Jan 22.

34.

Quantitative histopathology identifies patients with thin melanomas who are at risk for metastases.

Glazer ES, Bartels PH, Lian F, Kha ST, Morgan SS, da Silva VD, Yozwiak ML, Bartels HG, Cranmer LD, de Oliveira JK, Alberts DS, Warneke JA, Krouse RS.

Melanoma Res. 2016 Jun;26(3):261-6. doi: 10.1097/CMR.0000000000000236.

PMID:
26795273
35.

Phase IIB Randomized Study of Topical Difluoromethylornithine and Topical Diclofenac on Sun-Damaged Skin of the Forearm.

Jeter JM, Curiel-Lewandrowski C, Stratton SP, Myrdal PB, Warneke JA, Einspahr JG, Bartels HG, Yozwiak M, Bermudez Y, Hu C, Bartels P, Alberts DS.

Cancer Prev Res (Phila). 2016 Feb;9(2):128-34. doi: 10.1158/1940-6207.CAPR-15-0232. Epub 2015 Dec 28.

36.

A laser microdissection-based workflow for FFPE tissue microproteomics: Important considerations for small sample processing.

Longuespée R, Alberts D, Pottier C, Smargiasso N, Mazzucchelli G, Baiwir D, Kriegsmann M, Herfs M, Kriegsmann J, Delvenne P, De Pauw E.

Methods. 2016 Jul 15;104:154-62. doi: 10.1016/j.ymeth.2015.12.008. Epub 2015 Dec 12.

PMID:
26690073
37.

Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis.

Kim JE, Roh E, Lee MH, Yu DH, Kim DJ, Lim TG, Jung SK, Peng C, Cho YY, Dickinson S, Alberts D, Bowden GT, Einspahr J, Stratton SP, Curiel-Lewandrowski C, Bode AM, Lee KW, Dong Z.

Oncogene. 2016 Aug 4;35(31):4091-101. doi: 10.1038/onc.2015.471. Epub 2015 Dec 21.

38.

Cancer Prevention: Obstacles, Challenges and the Road Ahead.

Meyskens FL Jr, Mukhtar H, Rock CL, Cuzick J, Kensler TW, Yang CS, Ramsey SD, Lippman SM, Alberts DS.

J Natl Cancer Inst. 2015 Nov 7;108(2). pii: djv309. doi: 10.1093/jnci/djv309. Print 2016 Feb. Review.

39.

Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: An NRG oncology/gynecologic oncology group study.

Hess LM, Huang HQ, Hanlon AL, Robinson WR, Johnson R, Chambers SK, Mannel RS, Puls L, Davidson SA, Method M, Lele S, Havrilesky L, Nelson T, Alberts DS.

Gynecol Oncol. 2015 Dec;139(3):541-5. doi: 10.1016/j.ygyno.2015.10.003. Epub 2015 Oct 9.

40.

Genetic ablation of caspase-7 promotes solar-simulated light-induced mouse skin carcinogenesis: the involvement of keratin-17.

Lee MH, Lim DY, Kim MO, Lee SY, Shin SH, Kim JY, Kim SH, Kim DJ, Jung SK, Yao K, Kundu JK, Lee HS, Lee CJ, Dickinson SE, Alberts D, Bowden GT, Stratton S, Curiel C, Einspahr J, Bode AM, Surh YJ, Cho YY, Dong Z.

Carcinogenesis. 2015 Nov;36(11):1372-80. doi: 10.1093/carcin/bgv110. Epub 2015 Aug 12.

41.

Quantifying and Reducing Uncertainties in Cancer Therapy.

Barrett HH, Alberts DS, Woolfenden JM, Liu Z, Caucci L, Hoppin JW.

Proc SPIE Int Soc Opt Eng. 2015 Feb 21;9412. pii: 94120N.

42.

Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin.

Bermudez Y, Stratton SP, Curiel-Lewandrowski C, Warneke J, Hu C, Bowden GT, Dickinson SE, Dong Z, Bode AM, Saboda K, Brooks CA, Petricoin EF 3rd, Hurst CA, Alberts DS, Einspahr JG.

Cancer Prev Res (Phila). 2015 Aug;8(8):720-8. doi: 10.1158/1940-6207.CAPR-14-0407. Epub 2015 Jun 1.

43.

Pilot study on the bioactivity of vitamin d in the skin after oral supplementation.

Curiel-Lewandrowski C, Tang JY, Einspahr JG, Bermudez Y, Hsu CH, Rezaee M, Lee AH, Tangrea J, Parnes HL, Alberts DS, Chow HH.

Cancer Prev Res (Phila). 2015 Jun;8(6):563-9. doi: 10.1158/1940-6207.CAPR-14-0280. Epub 2015 Apr 2.

44.

Salpingectomy as a means to reduce ovarian cancer risk.

Daly MB, Dresher CW, Yates MS, Jeter JM, Karlan BY, Alberts DS, Lu KH.

Cancer Prev Res (Phila). 2015 May;8(5):342-8. doi: 10.1158/1940-6207.CAPR-14-0293. Epub 2015 Jan 13. Review.

45.

A diagnostic evaluation model for complex research partnerships with community engagement: the partnership for Native American Cancer Prevention (NACP) model.

Trotter RT 2nd, Laurila K, Alberts D, Huenneke LF.

Eval Program Plann. 2015 Feb;48:10-20. doi: 10.1016/j.evalprogplan.2014.09.001. Epub 2014 Sep 19.

46.

Pathologic findings at risk-reducing salpingo-oophorectomy: primary results from Gynecologic Oncology Group Trial GOG-0199.

Sherman ME, Piedmonte M, Mai PL, Ioffe OB, Ronnett BM, Van Le L, Ivanov I, Bell MC, Blank SV, DiSilvestro P, Hamilton CA, Tewari KS, Wakeley K, Kauff ND, Yamada SD, Rodriguez G, Skates SJ, Alberts DS, Walker JL, Minasian L, Lu K, Greene MH.

J Clin Oncol. 2014 Oct 10;32(29):3275-83. doi: 10.1200/JCO.2013.54.1987. Epub 2014 Sep 8.

47.

A novel chemopreventive mechanism for a traditional medicine: East Indian sandalwood oil induces autophagy and cell death in proliferating keratinocytes.

Dickinson SE, Olson ER, Levenson C, Janda J, Rusche JJ, Alberts DS, Bowden GT.

Arch Biochem Biophys. 2014 Sep 15;558:143-52. doi: 10.1016/j.abb.2014.06.021. Epub 2014 Jul 5.

48.

Use of radiofrequency power to enable glow discharge optical emission spectroscopy ultrafast elemental mapping of combinatorial libraries with nonconductive components: nitrogen-based materials.

Gonzalez de Vega C, Alberts D, Chawla V, Mohanty G, Utke I, Michler J, Pereiro R, Bordel N, Gamez G.

Anal Bioanal Chem. 2014 Nov;406(29):7533-8. doi: 10.1007/s00216-014-7941-2. Epub 2014 Jul 6.

PMID:
24997536
49.

Appropriate use of complementary and alternative medicine approaches in gynecologic cancers.

Chase DM, Gibson SJ, Sumner DA, Bea JW, Alberts DS.

Curr Treat Options Oncol. 2014 Mar;15(1):14-26. doi: 10.1007/s11864-013-0269-x. Review.

PMID:
24398574
50.

Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia.

Garcia FA, Cornelison T, Nuño T, Greenspan DL, Byron JW, Hsu CH, Alberts DS, Chow HH.

Gynecol Oncol. 2014 Feb;132(2):377-82. doi: 10.1016/j.ygyno.2013.12.034. Epub 2014 Jan 2.

Supplemental Content

Loading ...
Support Center